title: Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.
abstract: To determine the first steps involved in the mechanism of action of aldosterone and its antagonists, we analysed the ligand-induced structural changes of the human mineralocorticoid receptor (hMR) translated in vitro. Limited chymotrypsin digestion of the receptor generated a 30 kDa fragment. Following binding of a ligand to hMR, the 30 kDa fragment became resistant to chymotrypsin proteolysis, indicating a change in the receptor conformation. Differences in sensitivity to chymotrypsin of the 30 kDa fragment were observed after binding of agonists and antagonists to hMR, suggesting that these two classes of ligands induced different hMR conformations. Several lines of evidence allowed us to identify the 30 kDa fragment as the subregion encompassing the C-terminal part of the hinge region and the ligand-binding domain (LBD) or hMR (hMR 711-984). (1) The 30 kDa fragment is not recognized by FD4, an antibody directed against the N-terminal region of hMR. (2) Aldosterone remains associated with the 30 kDa fragment after chymotrypsin proteolysis of the aldosterone-hMR complex. (3) A truncated hMR, lacking the last 40 C-terminal amino acids (hMR 1-944), yields a 26 kDa proteolytic fragment. In addition, we showed that the unbound and the aldosterone-bound 30 kDa fragment were both associated with heat-shock protein (hsp) 90, indicating that the ligand-induced conformational change takes place within the hetero-oligomeric structure and that the 711-984 region is sufficient for hsp90-MR interaction. We conclude that the ligand-induced conformational change of the receptor is a crucial step in mineralocorticoid action. It occurs within the LBD, precedes the release of hsp90 from the receptor and is dependent upon the agonist/antagonist nature of the ligand.
authors.affiliation: INSERM U246, Faculté de Médecine Xavier Bichat, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Couette
authors.forename: J
authors.initials: J
authors.lastname: Fagart
authors.forename: S
authors.initials: S
authors.lastname: Jalaguier
authors.forename: M
authors.initials: M
authors.lastname: Lombes
authors.forename: A
authors.initials: A
authors.lastname: Souque
authors.forename: M E
authors.initials: ME
authors.lastname: Rafestin-Oblin
mesh_terms: D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D002918:Chymotrypsin; D017931:DNA Primers / Q000235:genetics; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008024:Ligands; D008969:Molecular Sequence Data; D015394:Molecular Structure; D008970:Molecular Weight; D010446:Peptide Fragments / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D014176:Protein Biosynthesis; D011487:Protein Conformation; D011817:Rabbits; D018161:Receptors, Mineralocorticoid / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
chemical_list: D017931:DNA Primers; D008024:Ligands; D010446:Peptide Fragments; D018161:Receptors, Mineralocorticoid; D011994:Recombinant Proteins; D000450:Aldosterone; D002918:Chymotrypsin